Møllerud Stine, Frydenvang Karla, Pickering Darryl S, Kastrup Jette Sandholm
Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Jagtvej 162, DK-2100, Copenhagen Ø, Denmark.
Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Jagtvej 162, DK-2100, Copenhagen Ø, Denmark.
Neuropharmacology. 2017 Jan;112(Pt A):16-28. doi: 10.1016/j.neuropharm.2016.05.014. Epub 2016 May 26.
Kainate receptors belong to the family of ionotropic glutamate receptors. These receptors assemble from five subunits (GluK1-5) into tetrameric ion channels. Kainate receptors are located at both pre- and postsynaptic membranes in the central nervous system where they contribute to excitatory synaptic transmission and modulate network excitability by regulating neurotransmitter release. Dysfunction of kainate receptors has been implicated in several neurological disorders such as epilepsy, schizophrenia and depression. Here we provide a review on the current understanding of kainate receptor structure and how they bind agonists, antagonists and ions. The first structure of the ligand-binding domain of the GluK1 subunit was reported in 2005, seven years after publication of the crystal structure of a soluble construct of the ligand-binding domain of the AMPA-type subunit GluA2. Today, a full-length structure has been determined of GluK2 by cryo electron microscopy to 7.6 Å resolution as well as 84 high-resolution crystal structures of N-terminal domains and ligand-binding domains, including agonist and antagonist bound structures, modulatory ions and mutations. However, there are still many unanswered questions and challenges in front of us. This article is part of the Special Issue entitled 'Ionotropic glutamate receptors'.
红藻氨酸受体属于离子型谷氨酸受体家族。这些受体由五个亚基(GluK1 - 5)组装成四聚体离子通道。红藻氨酸受体位于中枢神经系统的突触前膜和突触后膜,在那里它们有助于兴奋性突触传递,并通过调节神经递质释放来调节网络兴奋性。红藻氨酸受体功能障碍与多种神经系统疾病有关,如癫痫、精神分裂症和抑郁症。在此,我们综述了目前对红藻氨酸受体结构以及它们如何结合激动剂、拮抗剂和离子的理解。2005年报道了GluK1亚基配体结合结构域的首个结构,这是在AMPA型亚基GluA2配体结合结构域的可溶性构建体晶体结构发表七年后。如今,通过冷冻电子显微镜已确定了分辨率为7.6 Å的GluK2全长结构,以及84个N端结构域和配体结合结构域的高分辨率晶体结构,包括结合激动剂和拮抗剂的结构、调节离子和突变结构。然而,我们面前仍有许多未解决的问题和挑战。本文是名为“离子型谷氨酸受体”的特刊的一部分。